De volgende fysio- en oedeempraktijken gebruiken DoctorLife apparatuur:

Huidtherapie Kempers
Emmapark 12
☎︎ 015 – 369 88 63
Van Leeuwen Huid- en Oedeemtherapie
Kampveld 10k
2611 DA  DELFT
☎︎ 015 – 215 19 66
Huidtherapie Gelderblom
Praktijk voor huid- en Oedeemtherapie
Dillenburgsingel 10
☎︎ 06 22 33 71 59
M.L. Berends
Praktijk voor Fysiotherapie/oedeemtherapie en acupunctuur
Da Costastraat 46
☎︎ 079 – 316 82 05
Fysiotherapeutisch Centrum Palenstein
Van Aalstlaan 392
☎︎ 079 – 331 42 93
Fysiotherapie Hereweg
Hereweg 83
☎︎ 045 – 533 24 70

Huidtherapie Van Hilten
J.W. Hagemanstraat 48
☎︎ 06 12 76 40 65

Huidzorg Balans
Rijskade 1
tel. 06 15 86 79 48
Dorpsstraat 86
tel. 0172 58 78 02

Gezondheidscentrum De Elementen
Hongerlandsedijk 1098 (begane grond)
3201 LZ Spijkenisse

Medisch Centrum Stelle
Stelle 12G   (begane grond)
3191 KE Hoogvliet
Tel: 010-4387238
Fax: 010-4385924


MTC Zoetermeer
Peter Zuidhove 6
tel. 079 – 341 03 00
Praktijk voor Fysio- en Manuele Therapie Amerongen
Koenenstraat 1
tel. 0343 – 45 15 82




De meeste wetenschappelijke artikelen over medische toepassingen van IPC zijn in het engels. Onderstaand worden enige referenties gegeven.

Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs
Stanley G. Rockson et al         PLoS ONE 9(12):  doi:10.1371/journal.pone.0114597  December 3, 2014

Abstract: Lymphedema is a common complication of cancer therapeutics; its prevalence, treatment outcomes, and costs have been poorly defined. The objective of this study was to examine lymphedema prevalence among cancer survivors and to characterize changes in clinical outcomes and costs associated with a defined therapeutic intervention (use of a pneumatic compression devices [PCD]) in a representative, privately insured population.
Methods and Findings: Retrospective analysis of de-identified health claims data from a large national insurer for calendar years 2007 through 2013. Patients were required to have 12 months of continuous insurance coverage prior to PCD receipt (baseline), as well as a 12-month follow-up period. Analyses were performed for individuals with cancer-related lymphedema. Lymphedema prevalence was calculated: number of patients with a lymphedema claim in a calendar year divided by total number of enrollees. The impact of PCD use was evaluated by comparing rates of a pre-specified set of health outcomes and costs for the 12 months before and after, respectively, PCD receipt. Lymphedema prevalence among cancer survivors increased from 0.95% in 2007 to 1.24% in 2013. PCD use was associated with decreases in rates of hospitalizations (45% to 32%), outpatient hospital visits (95% to 90%),cellulitis diagnoses (28% to 22%,), and physical therapy use (50% to 41%,). The average baseline health care costs were high ($53,422) but decreased in the year after PCD acquisition ($11,833).
Conclusions:Lymphedema is a prevalent medical condition that is often a defining attribute of cancer survivorship. The problem is associated with high health care costs; Treatment (in this instance, use of PCD) is associated with significant decreases in adverse clinical outcomes and costs.

For the full article click HERE

Intermittent Pneumatic Compression Therapy: A systematic review.
J.L.Feldman et al.    Lymphology 45 (2012) 13-25

Abstract: IPC therapy is an effective modality to reduce the volume of the lymphedemattous limbs alone or in conjunction with other modalities of therapy such as decongestive therapy. However, there is no consensus on the frequency of treatment parameters for IPC devices. We undertook a systematic review of contemporary peer-reviewed literature (2004-2011) to evaluate the evidence for use of IPC in the treatment of lymphedema. In select patients, IPC use may provide an acceptable home-based treatment modality in addition to wearing compression garments.

For the full article click HERE


Intermittent pneumatic compression acts synergistically with manual lymphatic drainage in complex decongestive physiotherapy for breast cancer treatment-related lymphedema.
G. Szolnoky, B. Lakatos, T. Keskeny, E. Varga, M. Varga, A. Dobozy, L. Kemény;  Lymphology 42 (2009) 188-194

Abstract: The application of intermittent pneumatic compression (IPC) as a part of complex decongestive physiotherapy (CDP) remains controversial. The aim of this study was to investigate whether the combination of IPC with manual lymph drainage (MLD) could improve CDP treatment outcomes in women with secondary lymphedema after breast cancer treatment. A randomized study was undertaken with 13 subjects receiving MLD (60 min) and 14 receiving MLD (30 min) plus IPC (30 min) followed by standardized components of CDP including multilayered compression bandaging, physical exercise, and skin care 10 times in a 2-week-period. Efficacy of treatment was evaluated by limb volume reduction and a subjective symptom questionnaire at end of the treatment, and one and two months after beginning treatment. The two groups had similar demographic and clinical characteristics. Mean reductions in limb volumes for each group at the end of therapy, and at one and two months were 7.93% and 3.06%, 9.02% and 2.9%, and 9.62% and 3.6%, respectively (p<0.05 from baseline for each group and also between groups at each measurement). Although a significant decrease in the subjective symptom survey was found for both groups compared to baseline, no significant difference between the groups was found at any time point. The application of IPC with MLD provides a synergistic enhancement of the effect of CDP in arm
volume reduction.

For the full article click HERE


Effect of Air Compression Physiotherapy
Daesung Maref   (Internal Publication)

Abstract: An overview is given of the application of IPC in the physiotherapy practice.

For the full publication click HERE


Doctor Life Intermittent Pneumatic Compression Systems
Daesung Maref   (Internal Publication)

Abstract: Doctor Life IPC therapy systems are total solution devices applying air compression to help recovering from or preventing various diseases like Atherosclerosis, DVT/PE, Lymphedema, Chronis Venous Insufficiency (CVI), Varicosis, Post-paralytic (post-stroke, spinal cord injury), Post-mastectomy, Cellulite, etc.
IPC was proved suitable for blood ciculation. It is remarkably effective to promote venous return, to strengthen arterial infusion, to remove edema and to weaken coagulation. In addition, it is helpful to ameliorate anemia and to heighten oxygen combination.

For the full publication click HERE